Werner syndrome RecQ helicase-IN-2 (example 57) is a potent Werner syndrome RecQ DNA helicase enzyme (WRN) inhibitor and can be used in cancer research.
Werner syndrome RecQ helicase-IN-2 (example 57) has an IC50 value of 100 nM for WRN ATPase and GI50 values of 100 nM and >10 μM for SW48 and DLD1 WRN-KO cell lines, respectively[1].
References:
[1]. Triazolo-pyrimidine analogues for treating diseases connected to the inhibiton of werner syndrome recq helicase (wrn). WO2022249060